InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Konidaris Tasos, 首席财务官. Officer active across 1 company, notably Amneal Pharmaceuticals, Inc.. Aggregated, 12 disclosures have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €2.1m. Activity tracked since 5 March 2025. The latest transaction was filed on 13 August 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
Konidaris Tasos is Executive Vice President & CFO at Amneal Pharmaceuticals, Inc. He has 12 filings in total, and across the 12 most recent sampled filings from 2022-03-03 to 2026-03-05, sales total EUR 2108643 and the most frequent transaction nature is option exercise.